Audio By Carbonatix
The long arm of the law gave the drug company Pfizer Inc. a couple of pretty firm slaps Wednesday, one of which will bring close to $1 million to Arizona.
As part of a settlement for a multi-state federal lawsuit, the company has agreed to pay $33 million to 41 different states as punishment for misleading marketing tactics in promoting Geodon, an anti-psychotic drug used to treat schizophrenia.
Arizona’s cut: At lease $830,000 according to Attorney General Terry Goddard.
“Companies are not at liberty to pump up their sales by promoting drugs for uses not approved by the FDA,” Goddard says in a press release. “These settlements should send a powerful message throughout the pharmaceutical industry.”
When news happens, Phoenix New Times is there —
Your support strengthens our coverage.
We’re aiming to raise $30,000 by December 31, so we can continue covering what matters most to you. If New Times matters to you, please take action and contribute today, so when news happens, our reporters can be there.
The message is probably pretty clear. This settlement is a mere drop in the bucket compared to the record $2.3 billion settlement Pfizer reached with the federal government yesterday, which was the largest corporate penalty in U.S. history
Come on, Terry, you can’t get Arizona get a piece of that action?
